Home / Companies / Signiosbio / Trends
Signiosbio H-1B trends
Quarterly LCA aggregate trend points for Signiosbio. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Signiosbio span 2016 Q2 to 2025 Q4, peaking at 11 filings in 2019 Q2.
The most recent reported period (2025 Q4) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 6 | 4 | 3 | $72,287 | $78,984 | 4 | 66.7% |
| 2017 Q2 | 3 | 2 | 1 | $90,667 | $85,114 | 2 | 66.7% |
| 2018 Q2 | 2 | 2 | 2 | $68,250 | $66,768 | 2 | 100.0% |
| 2019 Q2 | 11 | 7 | 2 | $101,636 | $92,725 | 11 | 100.0% |
| 2020 Q4 | 1 | 1 | 1 | $108,202 | $108,202 | 1 | 100.0% |
| 2021 Q1 | 1 | 1 | 1 | $87,610 | $87,610 | 1 | 100.0% |
| 2021 Q2 | 1 | 1 | 1 | $87,610 | $87,610 | 1 | 100.0% |
| 2021 Q3 | 3 | 2 | 1 | $87,610 | $87,610 | 3 | 100.0% |
| 2022 Q2 | 1 | 1 | 1 | $150,000 | $127,878 | 1 | 100.0% |
| 2022 Q3 | 1 | 1 | 1 | $70,000 | $62,941 | 1 | 100.0% |
| 2022 Q4 | 2 | 2 | 2 | $87,000 | $86,424 | 2 | 100.0% |
| 2023 Q1 | 1 | 1 | 1 | $170,000 | $129,002 | 1 | 100.0% |
| 2023 Q2 | 1 | 1 | 1 | $170,000 | $129,002 | 1 | 100.0% |
| 2023 Q3 | 1 | 1 | 1 | $68,000 | $65,125 | 1 | 100.0% |
| 2024 Q1 | 1 | 1 | 1 | $102,000 | $101,816 | 1 | 100.0% |
| 2024 Q3 | 2 | 1 | 1 | $124,259 | $124,259 | 2 | 100.0% |
| 2024 Q4 | 1 | 1 | 1 | $112,258 | $112,258 | 1 | 100.0% |
| 2025 Q1 | 1 | 1 | 1 | $166,400 | $166,400 | 1 | 100.0% |
| 2025 Q2 | 2 | 2 | 2 | $140,234 | $140,234 | 2 | 100.0% |
| 2025 Q3 | 1 | 1 | 1 | $75,774 | $75,774 | 1 | 100.0% |
| 2025 Q4 | 2 | 2 | 2 | $92,092 | $92,092 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Signiosbio changed over time?
- H-1B LCA filings for Signiosbio span 2016 Q2 to 2025 Q4, peaking at 11 filings in 2019 Q2. The most recent reported period (2025 Q4) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=signiosbio&metric=lca_countJSON